An oral composition in tablet form containing therapeutic amounts of alendronate sodium for release of the alendronate sodium in the stomach and by passing the oesophagus, comprising a compacted granulated core with the alendronate sodium embedded in an inert fiber matrix, lined with a moisture barrier film and encl...
[Class : 5] Pharmaceutical And Medical Preparation; Medicinal Preparations For Use In Oncology; Pharmaceutical Preparations And Substances For Use In Oncology; Anti Cancer Preparations; Pharmaceutical Preparations, Substances And Compositions For The Treatment And Prevention Of Cancer; Biopharmaceuticals For The Treatment Of Cancer.
[Class : 5] Pharmaceutical And Medical Preparation; Medicinal Preparations For Use In Oncology; Pharmaceutical Preparations And Substances For Use In Oncology; Anti Cancer Preparations; Pharmaceutical Preparations, Substances And Compositions For The Treatment And Prevention Of Cancer; Biopharmaceuticals For The Treatment Of Cancer.
View +262 more Brands for Khandelwal Laboratories Private Limited.
Charges
43 Crore
30 January 2015
Axis Bank Limited
5 Crore
19 April 2011
Punjab National Bank
1 Crore
23 February 2011
Punjab National Bank
1 Crore
30 November 2007
Punjab National Bank
11 Crore
16 May 2007
Punjab National Bank
3 Crore
12 September 2006
Punjab National Bank
2 Crore
12 April 2005
Punjab National Bank
10 Crore
28 June 2004
Punjab National Bank
10 Crore
12 April 2005
Others
0
16 May 2007
Punjab National Bank
0
30 November 2007
Others
0
28 June 2004
Others
0
19 April 2011
Punjab National Bank
0
30 January 2015
Axis Bank Limited
0
12 September 2006
Punjab National Bank
0
23 February 2011
Punjab National Bank
0
12 April 2005
Others
0
16 May 2007
Punjab National Bank
0
30 November 2007
Others
0
28 June 2004
Others
0
19 April 2011
Punjab National Bank
0
30 January 2015
Axis Bank Limited
0
12 September 2006
Punjab National Bank
0
23 February 2011
Punjab National Bank
0
Documents
Form Addendum to AOC-4 CSR-18032024
Form MGT-7-27122023_signed
Optional Attachment-(1)-09112023
Copy of MGT-8-09112023
List of share holders, debenture holders;-09112023
Form MGT-7-09112023
Form MSME FORM I-30102023
Form AOC-4(XBRL)-07112023_signed
XBRL document in respect Consolidated financial statement-28102023
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-28102023
Form MSME FORM I-11092023_signed
Form MSME FORM I-10092023_signed
Form MSME FORM I-29042023_signed
Form Addendum to AOC-4 CSR-19012023_signed
Form MGT-7-28112022
Optional Attachment-(3)-28112022
Optional Attachment-(2)-28112022
Optional Attachment-(1)-28112022
Copy of MGT-8-28112022
List of share holders, debenture holders;-28112022
XBRL document in respect Consolidated financial statement-08112022
Optional Attachment-(2)-08112022
Optional Attachment-(3)-08112022
Optional Attachment-(1)-08112022
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-08112022